World's Best Scientists 2026 revealed!
Hiroaki Kataoka

Hiroaki Kataoka

D-Index & Metrics

Biology and Biochemistry

D-Index
60
Citations
10810
World Ranking
12129
National Ranking
830

Overview

Hiroaki Kataoka is affiliated with the University of Miyazaki in Japan and has made contributions in the field of medicine with a primary focus on oncology, surgery, immunology, molecular biology, and genetics. Their research spans multiple subfields, reflecting a comprehensive interest in biomedical sciences.

Their research topics encompass areas such as:

  • Vector-Borne Animal Diseases
  • T-cell and Retrovirus Studies
  • Liver physiology and pathology
  • Vascular Tumors and Angiosarcomas
  • Salivary Gland Tumors Diagnosis and Treatment
  • Coagulation, Bradykinin, Polyphosphates, and Angioedema
  • Viral-associated cancers and disorders

Recent publications by Hiroaki Kataoka include:

  • "Protease-activated receptor-2 accelerates intestinal tumor formation through activation of nuclear factor-κB signaling and tumor angiogenesis in ApcMin/+ mice" (2020), published in Cancer Science
  • "Dysregulation of Type II Transmembrane Serine Proteases and Ligand-Dependent Activation of MET in Urological Cancers" (2020), published in International Journal of Molecular Sciences
  • "TP53 and PTEN mutations were shared in concurrent germ cell tumor and acute megakaryoblastic leukemia" (2020), published in BMC Cancer
  • "Excessive Intake of High-Fructose Corn Syrup Drinks Induces Impaired Glucose Tolerance" (2021), published in Biomedicines
  • "Severe Fever with Thrombocytopenia Syndrome Accompanied by Invasive Pulmonary Aspergillosis: An Autopsy Case" (2021), published in Viruses

Frequent coauthors contributing alongside Kataoka include:

  • Takumi Kiwaki
  • Tsuyoshi Fukushima
  • Makiko Kawaguchi
  • Hiroyuki Tanaka
  • Koji Yamamoto

Key venues of publication where Kataoka's work appears frequently are:

  • Research Square (Research Square)
  • Journal of Medical Case Reports
  • Cancer Science
  • International Journal of Molecular Sciences
  • Journal of Biological Chemistry

The body of work by Hiroaki Kataoka illustrates an interdisciplinary focus on medical research, with a particular emphasis on molecular and clinical oncology. The variety of topics and collaborations reflects continuous engagement in relevant biomedical research areas.

Best Publications

  • The Human Tumor Cell-derived Collagenase Stimulatory Factor (Renamed EMMPRIN) Is a Member of the Immunoglobulin Superfamily

    Chitra Biswas;Ying Zhang;Rosana DeCastro;Huiming Guo

  • Tumor Cell-derived Collagenase-stimulatory Factor Increases Expression of Interstitial Collagenase, Stromelysin, and 72-kDa Gelatinase

    Hiroaki Kataoka;Rosana DeCastro;Stanley Zucker;Chitra Biswas

  • Factor XII inhibition reduces thrombus formation in a primate thrombosis model

    Anton Matafonov;Anton Matafonov;Philberta Y. Leung;Adam E. Gailani;Stephanie L. Grach

  • Hepatocyte growth factor activator inhibitor type 1 is a specific cell surface binding protein of hepatocyte growth factor activator (HGFA) and regulates HGFA activity in the pericellular microenvironment.

    Hiroaki Kataoka;Takeshi Shimomura;Toshiya Kawaguchi;Ryouichi Hamasuna

  • Distribution of Hepatocyte Growth Factor Activator Inhibitor Type 1 (HAI-1) in Human Tissues: Cellular Surface Localization of HAI-1 in Simple Columnar Epithelium and Its Modulated Expression in Injured and Regenerative Tissues

    Hiroaki Kataoka;Tatsuo Suganuma;Takeshi Shimomura;Hiroshi Itoh

  • Proanthocyanidin from Blueberry Leaves Suppresses Expression of Subgenomic Hepatitis C Virus RNA

    Masahiko Takeshita;Yo-ichi Ishida;Ena Akamatsu;Yusuke Ohmori

  • Roles of hepatocyte growth factor (HGF) activator and HGF activator inhibitor in the pericellular activation of HGF/scatter factor.

    Hiroaki Kataoka;Shiro Miyata;Shunro Uchinokura;Hiroshi Itoh

  • Activation of hepatocyte growth factor/scatter factor in colorectal carcinoma.

    Hiroaki Kataoka;Ryouichi Hamasuna;Hiroshi Itoh;Naomi Kitamura

  • Cohort migration of carcinoma cells.Differentiated colorectal carcinoma cells move as coherent cell clusters or sheets

    Kazuki Nabeshima;T. Inoue;Y. Shimao;H. Kataoka

  • Human keratinocytes express EMMPRIN, an extracellular matrix metalloproteinase inducer.

    Rosana DeCastro;Ying Zhang;Huiming Guo;Hiroaki Kataoka

  • Glypican-3 is a prognostic factor and an immunotherapeutic target in hepatocellular carcinoma

    Yukihiro Haruyama;Hiroaki Kataoka

  • Molecular genetic cascades for external genitalia formation: an emerging organogenesis program.

    G. Yamada;K. Suzuki;R. Haraguchi;S. Miyagawa

  • Mechanisms of Hepatocyte Growth Factor Activation in Cancer Tissues

    Makiko Kawaguchi;Hiroaki Kataoka

  • Regulation of matrix metalloproteinase-2 (MMP-2) by hepatocyte growth factor/scatter factor (HGF/SF) in human glioma cells: HGF/SF enhances MMP-2 expression and activation accompanying up-regulation of membrane type-1 MMP.

    Ryouichi Hamasuna;Hiroaki Kataoka;Takuzou Moriyama;Hiroshi Itoh

  • Expression of c‐Met correlates with grade of malignancy in human astrocytic tumours: an immunohistochemical study

    K. Nabeshima;Y. Shimao;S. Sato;H. Kataoka

  • Enhanced Tumor Growth and Invasiveness in Vivo by a Carboxyl-Terminal Fragment of α1-Proteinase Inhibitor Generated by Matrix Metalloproteinases: A Possible Modulatory Role in Natural Killer Cytotoxicity

    Hiroaki Kataoka;Hirofumi Uchino;Takeshi Iwamura;Motoharu Seiki

  • Anti-glioma therapy with temozolomide and status of the DNA-repair gene MGMT

    Tsuyoshi Fukushima;Hideo Takeshima;Hiroaki Kataoka

  • Silencing of Insulin-like Growth Factor-binding Protein-2 in Human Glioblastoma Cells Reduces Both Invasiveness and Expression of Progression-associated Gene CD24

    Tsuyoshi Fukushima;Tomoaki Tezuka;Takeshi Shimomura;Shinichi Nakano

  • Clinical relevance of hepsin and hepatocyte growth factor activator inhibitor type 2 expression in renal cell carcinoma

    Hironori Betsunoh;Shoichiro Mukai;Yutaka Akiyama;Tsuyoshi Fukushima

  • Identification of CCDC6-RET Fusion in the Human Lung Adenocarcinoma Cell Line, LC-2/ad

    Daisuke Matsubara;Yoshihiko Kanai;Shumpei Ishikawa;Shiori Ohara

Frequent Co-Authors

Hiroshi Itoh
Hiroshi Itoh Yamaguchi University
Hiroshi Itoh
Hiroshi Itoh Keio University
Naomi Kitamura
Naomi Kitamura Tokyo Institute of Technology
Keiji Miyazawa
Keiji Miyazawa University of Yamanashi
Hiroyuki Tanaka
Hiroyuki Tanaka Kyushu University
Chen-Yong Lin
Chen-Yong Lin Georgetown University
Kazuya Shimoda
Kazuya Shimoda University of Miyazaki
Yukifumi Nawa
Yukifumi Nawa Khon Kaen University
Kiyoshi Mori
Kiyoshi Mori University of Shizuoka
Dan Lindholm
Dan Lindholm Minerva Foundation

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Hiroaki Kataoka

Trending Scientists

Recently Published Articles